3-amino-1-methyl-5-phenyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one | 564462-38-0

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 3-amino-1-methyl-5-phenyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one
• 英文别名: (RS)-3-amino-1-methyl-5-phenyl-1,3,4,5-tetrahydro-benzo[b][1,4]diazepin-2-one；3-amino 1-methyl-5-phenyl-1,3,4,5-tetrahydro-(2H)-1,5-benzodiazepine-2-one；3-Amino-1-methyl-5-phenyl-3,4-dihydro-1,5-benzodiazepin-2-one
• CAS: 564462-38-0
• 化学式: C₁₆H₁₇N₃O
• 分子量: 267.33
• InChiKey: VCKOSXIHOXMFFN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  20
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  49.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-amino-1-methyl-5-phenyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one 、 N-(叔丁氧羰基)-L-2-苯甘氨酸 在 2-乙氧基-1-乙氧碳酰基-1,2-二氢喹啉 作用下， 反应 6.0h， 生成 3-[N'-(t-butoxycarbonyl)-(S)-phenylglycinyl]-amino-1-methyl-5-phenyl-1,3,4,5-tetrahydro-(2H)-1,5-benzodiazepine-2-one 、 3-[N'-(t-butoxycarbonyl)-(R)-phenylglycinyl]-amino-1-methyl-5-phenyl-1,3,4,5-tetrahydro-(2H)-1,5-benzodiazepine-2-one
  参考文献：
  名称：

  Polycyclic α-amino-ε-caprolactams and related compounds

  摘要：

  披露了多环α-氨基-ε-己内酯和相关化合物，这些化合物在制备β-淀粉样肽释放抑制剂和/或其合成中起到合成中间体的作用。

  公开号：

  US06958330B1
• 作为产物：
  描述：

  3-azido-1-methyl-5-phenyl-1,3,4,5-tetrahydro-(2H)-1,5-benzodiazepine-2-one 在 三苯基膦 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 16.0h， 生成 3-amino-1-methyl-5-phenyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one
  参考文献：
  名称：

  Polycyclic α-amino-ε-caprolactams and related compounds

  摘要：

  披露了多环α-氨基-ε-己内酯和相关化合物，这些化合物在制备β-淀粉样肽释放抑制剂和/或其合成中起到合成中间体的作用。

  公开号：

  US06958330B1

文献信息

• Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
  申请人：——

  公开号：US20020045747A1

  公开（公告）日：2002-04-18

  Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

  公开了抑制β-淀粉样肽释放和/或其合成的化合物，因此可用于治疗阿尔茨海默病。还公开了包含抑制β-淀粉样肽释放和/或其合成的化合物的药物组合物，以及使用这些药物组合物预防性和治疗性治疗阿尔茨海默病的方法。
• Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds
  申请人：Elan Pharmaceuticals, Inc.

  公开号：US06528505B1

  公开（公告）日：2003-03-04

  Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

  公开了抑制β-淀粉样肽释放和/或其合成的化合物，因此可用于治疗阿尔茨海默病。还公开了包含抑制β-淀粉样肽释放和/或其合成的化合物的药物组合物，以及使用这些药物组合物预防性和治疗性治疗阿尔茨海默病的方法。
• Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds
  申请人：Athena Neurosciences, Inc.

  公开号：US06506782B1

  公开（公告）日：2003-01-14

  Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

  公开了抑制β-淀粉样肽释放和/或其合成的化合物，因此可用于治疗阿尔茨海默病。还公开了包含抑制β-淀粉样肽释放和/或其合成的化合物的药物组合物，以及使用这些药物组合物预防性和治疗性地治疗阿尔茨海默病的方法。
• Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds
  申请人：Elan Pharmaceuticals, Inc.

  公开号：US06509331B1

  公开（公告）日：2003-01-21

  Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

  公开了抑制β-淀粉样肽释放和/或其合成的化合物，因此可用于治疗阿尔茨海默病。还公开了包含抑制β-淀粉样肽释放和/或其合成的化合物的药物组合物，以及使用这些药物组合物预防性和治疗性地治疗阿尔茨海默病的方法。
• Malonamide derivatives
  申请人：Flohr Alexander

  公开号：US20050054633A1

  公开（公告）日：2005-03-10

  The invention relates to malonamide derivatives of formula wherein each of the variables are as defined herein and to pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates and diastereomeric mixtures thereof. These compounds are γ-secretase inhibitors and may be used for the treatment of Alzheimer's disease.

  该发明涉及公式的马隆酰胺衍生物，其中每个变量如本文所定义，并且涉及药学上可接受的酸盐加合物、光学纯的对映体、拉氏体和二对映异构体混合物。这些化合物是γ-分泌酶抑制剂，可用于治疗阿尔茨海默病。